Connect with us

Featured

ParcelPal (PKG.CN) (PTNYF) Achieves Milestone of Delivering Over 2,500,000 Packages

Joe Samuel

Published

on

delivery stocks to buy

VANCOUVER, British Columbia, June 21, 2019 (GLOBE NEWSWIRE) — ParcelPal Technology Inc. (“ParcelPal” or the “Company”), (CSE:PKG) (PT0.F) (PTNYF) is pleased to announce they have achieved a major milestone of delivering over 2,500,000 packages to date. Furthermore, the Company has also had early success in Saskatchewan across all verticals including Cannabis. The company plans to engage in further partnerships, enter new cities and will report on progress in the near future. As time and regulations allow, ParcelPal’s cannabis network will continue to grow, with the goal of capturing a major piece of North America’s expected $60.0B legal cannabis market.

[Special Report] On-Demand Tech Takeover: Here’s What You Should Know

This milestone provides further validation that ParcelPal’s innovative technology is revolutionizing the on-demand delivery space as consumers and merchants are turning to the company to make this process both simple and efficient. ParcelPal has shifted the paradigm from a simple on-demand delivery company to being a full comprehensive eCommerce platform that allows consumers in to purchase anything legal and have those goods delivered in under an hour. ParcelPal’s go-forward plan includes pushing the ParcelPal platform on multiple consumer verticals in addition to further expanding their reach across Canada and the US.

We are continuously engaging in business development within Canada and the US to find other growth catalysts, whilst expanding existing partnerships in all verticals, including Cannabis and Liquor as these would result in higher margins and are significantly underserviced segments. The Company is still focusing their efforts on user acquisition, small business and large eCommerce contracts and various verticals for delivery. Since the launch of operations in late July 2017, the Company has grown revenue over 802% from 2017 to 2018. The Company expects this growth to continue as we expand our footprint across Canada and the US.

President and CEO, Kelly Abbott states, “We are extremely excited to have achieved this major milestone of 2,500,000. Our growth over the past year has been tremendous and we’re looking forward to taking advantage of the many opportunities that have presented themselves for the remaining part of the year specifically in the liquor and Cannabis space with near-term plans to enter Ontario. I would especially like to thank my team for all of the hard work and dedication to continue achieving milestones.”

About ParcelPal Technology Inc.

ParcelPal is a technology-driven logistics company that connects consumers to the goods they love. Customers can shop at partner businesses and through the ParcelPal technology receive their purchased goods within an hour.  The Company offers on-demand delivery of merchandise from leading retailers, restaurants, medical marijuana dispensaries and liquor stores in Vancouver and soon in major cities Canada-wide.

ParcelPal Website: www.parcelpal.com

The Canadian Securities Exchange (“CSE”) or any other securities regulatory authority has not reviewed and does not accept responsibility for the adequacy or accuracy of this news release that has been prepared by management.

CSE – Symbol: PKG
FSE – Symbol: PT0
OTC – Symbol: PTNYF

Contact: Peter Hinam, Investor Relations – peter@parcelpal.com 

Forward Looking Information

We seek safe harbour

This news release contains forward looking statements relating to the Proposed Transaction, and the future potential of ParcelPal.  Forward looking statements are often identified by terms such as “will”, “may”, “should”, “intends”, “anticipates”, “expects”, “plans” and similar expressions.  All statements other than statements of historical fact, included in this release are forward looking statements that involve risks and uncertainties.  These risks and uncertainties include, without limitation, the risk that the Proposed Transaction will not be completed due to, among other things, failure to execute definitive documentation, failure to complete satisfactory due diligence, failure to receive the approval of the CSE and the risk that ParcelPal will not be successful due to, among other things, general risks relating to the mobile application industry, failure of ParcelPal to gain market acceptance and potential challenges to the intellectual property utilized in ParcelPal.  There can be no assurance that any forward looking statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. 

The Company cannot guarantee that any forward looking statement will materialize and the reader is cautioned not to place undue reliance on any forward looking information.  Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.  Forward looking statements contained in this news release are expressly qualified by this cautionary statement.  The forward looking statements contained in this news release are made as of the date of this news release and the Company will only update or revise publicly any of the included forward looking statements as expressly required by Canadian securities laws.

Continue Reading
Click to comment

Featured

What Does The Disney (DIS) Plus, Amazon Deal Mean For Investors?

Jon Phillip

Published

on

DIS stocks to buy Disney +

There is no doubt that 2019 and the years beyond are going to be definite by the ‘streaming wars’ between some of the biggest companies in the world. The imminent entry of a behemoth like Disney (DIS) has raised the stakes even higher and on Thursday the entertainment company made another significant announcement.

During the company’s conference call for the fourth-quarter earnings, the Chief Executive Officer of Disney Bob Iger stated that the streaming serving Disney+ is going to be available on Amazon Fire TV.

[MARKET PREVIEW] The $40 Billion Dollar Content Gold Rush

Major Development For Content Providers

This is a major development, considering the fact that Disney had earlier said that the service might not be available on products owned by Amazon due to advertising disagreements.

However, that is not all. Iger went on to state that the service will also be made available on Smart TV manufactures by LG and Samsung. During the conference call, the Disney CEO said, “We’re pleased to announce partnerships with Amazon Fire [TV], LG, and Samsung devices.”

It is a major development for a streaming service that is trying to capture market share quickly from Netflix. Availability on Amazon Fire makes it accessible to a far bigger pool of potential customers. That is why this particular announcement is so important.

[MARKET PREVIEW] The $40 Billion Dollar Content Gold Rush

Where Does This Leave Netflix?

There are certain added benefits of the availability of Amazon Fire TV. The Disney+ app has the ability to sync with the built-in search engine on Amazon. Therefore, users will be able to request particular content by stating it to the personal assistant Alexa.

It goes without saying that the development has come as a big boost for Disney+. It’s ahead of the much-anticipated launch on November 12. The price of the service sits cheaper than Netflix’s cheapest package. It’s also going to be a highly cut-throat battle between the two companies. That said, other services are also coming soo. The ‘streaming wars’ are going to be the theme of 2020.

[MARKET PREVIEW] The $40 Billion Dollar Content Gold Rush

Continue Reading

Biotechnology

Biotech Stocks To Watch This Week

A. Lawrence

Published

on

make money with penny stocks biotech

With Biotech Continuing Higher, Are These Buys Or Sells This Week?

Biotech penny stocks have proven to be one of the best sectors for investments. That’s as far as the stock market is concerned. If experts are to be believed then it may continue to be among the best options in the years to come. That being said, it does not mean that investing in biotech stocks is an easy ride.

An investor needs to conduct a lot of research and also watch the market closely. Similar to other high-risk industries, volatility is a big factor. At any given point in time, a bad report could send stocks plummeting. Similarly, one good DA report can trigger a monster move. Here is a quick look at a few biotech penny stocks which made moves recently. Will they be better stocks to buy or avoid this month?

GT Biopharma Inc. (GTBP)

This company’s stock made new 3 month highs on October 22. GT Biopharma (GTBP) announced that its solid tumor targeting TriKE killed a non-small cell lung cancer tumor cell. This is a major development news for the company’s TriKE platform because the market potential for non-small lung cancer is big.

biotech stock to watch 2019

Non-small lung cancer accounts for 84% of all lung cancer diagnoses. Shareholders clearly felt this way, which may have been why GT Biopharma’s stock shot up by more than 25%.

There could be another potential reason why stockholders are reacting this way to the recent news. Earlier in October, the company announced that the design of HIV-TriKE was able to successfully target the HIV-Env protein.

This would allow the company’s TriKE technology to eliminate replicating HIV infected cells. Because of the success of TriKE with lung cancer cells, investors might feel that the company will be able to successfully destroy HIV cells. For more on GT Biopharma’s novel treatment pipeline and progress, click here.

WHAT CURING CANCER & HIV COULD MEAN FOR THIS COMPANY, ITS INVESTORS & THE WORLD!

Pieris Pharmaceuticals (PIRS)

The first stock to consider in the biotech sector with regards to the latest movements is that of Pieris Pharmaceuticals Inc (NASDAQ:PIRS). Back on November 5, the company announced that dose escalation monotherapy data with regards to one of its products is going to be presented at the Immunotherapy of Cancer (SITC) Annual Meeting that is going to be held at National Harbor, Maryland.

stock_price_mental

The medicine in question is PRS-343, which is meant for treating HER2-positive solid tumors. It goes without saying that it is a positive development and the Pieris stock has reacted positively to the news as well. Since the news broke, the stock has gained as much as 10%.

WHAT CURING CANCER & HIV COULD MEAN FOR THIS COMPANY, ITS INVESTORS & THE WORLD!

Foamix Pharmaceuticals (FOMX)

The other biotech stock that has been on a tear for much of the week is the Foamix Pharmaceuticals Ltd (NASDAQ:FOMX) stock. Back on October 18, the company announced that one of its products known as AMZEEQ has been approved by the United States Food and Drug Administration. The medicine in question is a topical foam and is meant for treating inflammatory lesions in both adults as well as pediatric patients, who are older than 9. That was the initial trigger for the rise in the stock price.

Last week, the company also published a peer review of the long term open-label safety of AMZEEQ and that proved to be the trigger for the rally. During the course of the week so far, the Foamix stock has soared by as much as 60%. This is a stock that should definitely be tracked by investors.

WHAT CURING CANCER & HIV COULD MEAN FOR THIS COMPANY, ITS INVESTORS & THE WORLD!

biotechnology stocks to buy

Pursuant to an agreement between Midam Ventures LLC and GT Biopharma (GTBP), Midam has been paid $100,000 for a period from October 1, 2019 to November 15, 2019. We may buy or sell additional shares of GT Biopharma (GTBP) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about GT Biopharma (GTBP). Click Here For Full Disclaimer.

Continue Reading

Featured

Stock Price Newsletter – November 11, 2019

Joe Samuel

Published

on

biotech stocks to watch

Streaming Stocks Take Aim At Winning The Content War

Over the past half a decade or so, the world of entertainment changed dramatically with the emergence of video streaming service Netflix Inc (NASDAQ: NFLX). As cord-cutting grew, Netflix’s continued to corner more and more of the streaming market. Here is a look at a few tech stocks to watch that could be set to prove themselves on this new battlefield.

Click Here To Read More


3 Defense Stocks to Watch in November

Over the years it has become abundantly clear that defense spending is going to rise every year and hence, defense stocks have naturally emerged as some of the safest investments in the market. However, the current unstable geopolitical situation in different corners of the world could lead to even more defense spending, if a Bank of America analyst is to be believed.

See For Yourself


3 Popular Biotech Stocks To Watch in November

Over the years, the biotech sector has been a bit of a gold mine when it comes to stocks and thousands of investors have been able to make significant profits by backing the right companies. The innovative solutions and technical advancements that have been brought into the sector by different companies is another factor behind the continued growth.

Read More

Continue Reading

Join Our Newsletter

Get stock alerts, news & trending stock alerts straight to your inbox!


Privacy Policy

We keep all user information pricate & promise to never spam.*

Stock Price Free Text List

Search Stock Price (StockPrice.com)




Trending

Subscribe Now & Begin Receiving Free Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Stock Market & Finance, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@stockprice.com